Affiliation:
1. Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
Abstract
Continuous-flow left ventricular assist devices (LVAD) are increasingly used as destination therapy in patients with end-stage heart failure and, with recent improvements in pump design, adverse event rates are decreasing. Implanted patients experience improved survival, quality of life (QoL) and functional capacity (FC). However, improvement in FC and QoL after implantation is not unequivocal, and this has implications for patient selection and preimplantation discussions with patients and relatives. This article identifies preimplantation predictors of lack of improvement in FC and QoL after continuous-flow LVAD implantation and discusses potential mechanisms, allowing for the identification of potential factors that can be modified. In particular, the pathophysiology behind insufficient improvement in peak oxygen uptake is discussed. Data are included from 40 studies, resulting in analysis of >700 exercise tests. Mean peak oxygen uptake was 13.4 ml/kg/min (equivalent to 48% of predicted value; 259 days after implantation, range 31–1,017 days) and mean 6-minute walk test distance was 370 m (182 days after implantation, range 43–543 days). Finally, the interplay between improvement in FC and QoL is discussed.
Subject
Cardiology and Cardiovascular Medicine
Reference85 articles.
1. Goldstein DJ, Meyns B, Xie R, et al. Third Annual Report From the ISHLT Mechanically Assisted Circulatory Support Registry: a comparison of centrifugal and axial continuous-flow left ventricular assist devices. J Hear Lung Transplant. 2019;38:352-363. https://doi.org/10.1016/j.healun.2019.02.004; PMID: 30945637.
2. de By TMMH, Mohacsi P, Gahl B, et al. The European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardio-Thoracic Surgery (EACTS): second report. Eur J Cardiothorac Surg 2018;53:309–16. https://doi.org/10.1093/ejcts/ezx320; PMID: 29029117.
3. Nakatani T, Sase K, Oshiyama H, et al. Japanese registry for Mechanically Assisted Circulatory Support: first report. J Heart Lung Transplant 2017;36:1087–96. https://doi.org/10.1016/j.healun.2017.08.002; PMID: 28942783.
4. Braun O, Nilsson J, Gustafsson F, et al. Continuous-flow LVADs in the Nordic countries: complications and mortality and its predictors. Scand Cardiovasc J 2019;53:14–20. https://doi.org/10.1080/14017431.2019.1583365; PMID: 30776923.
5. Mehra MR, Uriel N, Naka Y, et al. A fully magnetically levitated left ventricular assist device – final report. N Engl J Med 2019;380:1618–27. https://doi.org/10.1056/NEJMoa1900486; PMID: 30883052.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献